Bilcare Research is delighted to inform about the foundation of its legal entity in Shanghai. This isanother step to be closer to their Chinese customers. Bilcare Research (Shanghai) is able to provide
local sales, services and technical support to Chinese pharmaceutical industry.
Bilcare Research offers the global Pharmaceutical industry highest quality of all available barrier films
with the same properties and specifications – wherever customers are located. Besides packaging
materials, Bilcare Research offers its expertise in packaging design and drug delivery systems: From
Packaging to Blister Solutions. - Innovation is in our DNA. Bilcare Research Chinese technical and
commercial team are able to quick response and provide support to their customer to fully utilize
Bilcare Research technology, products, and services like Bilcare Optima™. Bilcare Optima™ identifies
drug’s optimal packaging materials while balancing cost and barrier-protection requirements, avoids
trial-and-error approach to drug testing, and therefore, significantly reduces time to market and stability
test costs.
The production sites for pharmaceutical blister packaging films deliver uniform quality – whether
produced in Europe, US or in Asia. The acquisition in coating capacity in Asia, the recently finalized
installation in a new laminator in the US and as well as the capacity increase in Europe are part of a strategic
investment program and show the dedication to the Pharmaceutical industry.
“Building up Bilcare Research (Shanghai) shows Bilcare Research’s focus on its customers producing in
China or for the Chinese market already” said Andreas Pfefferle, BU Head Global PPI. “We are also
looking forward to providing solutions to new Chinese customers and build up strong relationships with
them”.